Genetic susceptibility of MMP3 (rs3025058) variant allele in male football players with multiple ACL surgeries: a PCR-RFLP analysis

This study aimed to investigate the genetic susceptibility of the Matriks Metalloproteinaz-3 (MMP3) (rs3025058) gene variant allele and genotype distribution in male football players who actively participate in professional leagues and have undergone a minimum of two anterior cruciate ligament (ACL) surgeries. The study comprised 44 male football players who had undergone a minimum of two ACL surgeries and 61 male football players who had not undergone any ACL surgery. Participants’ blood samples were collected and DNA was extracted. Allele types were determined by analyzing the MMP3 (rs3025058) variant gene polymorphism using the restriction fragment length polymorphism (PCR-RFLP) method with appropriate primers and restriction enzymes. The results revealed no statistical significant differences in genotype distribution for 6A/6A, 5A/6A and 5A/5A (p = 0.736) or in 6A-allele frequency distribution between the control (CON) and ACL groups (Odds Ratio (OR) = 1.119, 95% Confidence Interval (CI): 0.637–1.965; p = 0.318). The analysis of both dominant (6A/6A vs. 5A/6A + 5A/5A) and recessive (6A/6A + 5A/6A vs. 5A/5A) models for the inheritance of the minor allele did not yield statistically significant difference, with odds ratios (OR) of 0.647 (95% CI: 0.283–1.478; p = 0.408) and 1.472 (95% CI: 0.506–4.281; p = 0.584), respectively. This study investigated the impact of MMP3 gene polymorphisms in ACL injuries, uncovering an intricate interplay between genetic and environmental factors that contribute to injury susceptibility. While some studies suggest potential links between MMP3 variants and ACL risks, the available information is inconclusive and necessitates additional confirmation in other demographics. Continued research is crucial to develop effective, personalized injury prevention strategies based on robust genetic markers.

ACL injuries; Matrix metalloproteinase-3; Gene polymorphisms; Male football player

[1] Küçük H, Ceylan L. Researching of hormone parameters of football players. Journal of Pharmaceutical Negative Results. 2022; 13: 754–759.

[2] Ghrairi M, Loney T, Pruna R, Malliaropoulos N, Valle X. Effect of poor cooperation between coaching and medical staff on muscle re-injury in professional football over 15 seasons. Open Access Journal of Sports Medicine. 2019; 10: 107–113.

[3] Ibrahim DA, Swenson A, Sassoon A, Bunn D, Faber K. Classifications in brief: the Tscherne classification of soft tissue injury. Clinical Orthopaedics and Related Research. 2017; 475: 560–564.

[4] Mingyu L, Liu Y, Gang J. Application of Chen Yuangao in the treatment of soft tissue injury of football players. Brazilian Journal of Sports Medicine. 2021; 27: 35–38.

[5] Bayraktar B, Dinç C, Yücesir İ, Taşkıran E. Injury evaluation of the Turkish national football team over six consecutive seasons. Turkish Journal of Trauma and Emergency Surgery. 2011; 17: 313–317.

[6] Webster KE, Hewett TE. Meta-analysis of meta-analyses of anterior cruciate ligament injury reduction training programs. Journal of Orthopaedic Research. 2018; 36: 2696–2708.

[7] Lucarno S, Zago M, Buckthorpe M, Grassi A, Tosarelli F, Smith R, et al. Systematic video analysis of anterior cruciate ligament injuries in professional female soccer players. The American Journal of Sports Medicine. 2021; 49: 1794–1802.

[8] Brophy RH, Stepan JG, Silvers HJ, Mandelbaum BR. Defending puts the anterior cruciate ligament at risk during soccer: a gender-based analysis. Sports Health. 2015; 7: 244–249.

[9] Burland JP, Toonstra J, Werner JL, Mattacola CG, Howell DM, Howard JS. Decision to return to sport after anterior cruciate ligament reconstruction, part I: a qualitative investigation of psychosocial factors. Journal of Athletic Training. 2018; 53; 452–463.

[10] Freitas-Rodriguez S, Folgueras AR, Lopez-Otin C. The role of matrix metalloproteinases in aging: tissue remodeling and beyond. Biochimica et Biophysica acta (BBA)-Molecular Cell Research. 2017; 1864: 2015–2025.

[11] Ardern CL, Taylor NF, Feller JA, Webster KE. Return-to-sport outcomes at 2 to 7 years after anterior cruciate ligament reconstruction surgery. The American Journal of Sports Medicine. 2012; 40: 41–48.

[12] Sandon A, Werner S, Forssblad M. Factors associated with returning to football after anterior cruciate ligament reconstruction. Knee Surgery Sports Traumatology Arthroscopy. 2015; 23: 2514–2521.

[13] Waldén M, Krosshaug T, Bjørneboe J, Andersen TE, Faul O, Hägglund M. Three distinct mechanisms predominate in non-contact anterior cruciate ligament injuries in male professional football players: a systematic video analysis of 39 cases. British Journal of Sports Medicine. 2015; 49: 1452–1460.

[14] Fuller CW, Dick RW, Corlette J, Schmalz R. Comparison of the incidence, nature, and cause of injuries sustained on grass and new generation artificial turf by male and female football players. Part 1: match injuries. British Journal of Sports Medicine. 2007; 41: i20–i26.

[15] Waldén M, Hägglund M, Magnusson H, Ekstrand J. Anterior cruciate ligament injury in elite football: a prospective three cohort study. Knee Surgery, Sports Traumatology, Arthroscopy. 2011; 19: 11–19.

[16] Karayılan ŞŞ, Dönmez G, Babayeva N, Çıkrıkçı G, Yılmaz Y, Avkıran Y. Sports injuries and genetics. Journal of Sports Medicine. 2013; 48: 139–146.

[17] Griffin LY, Albohm MJ, Arendt EA, Bahr R, Beynnon BD, DeMaio M, et al. Update on ACL prevention: theoretical and practical guidelines. The American Journal of Sports Medicine. 2006; 34: 1512–1532.

[18] Ipekoglu G, Cakir HI, Bozkurt N, Bulbul A, Savkin S, Apaydin N. Genetic factors and anterior cruciate ligament injury risk in professional football players: COL3A1 (rs1800255) and COL5A1 (rs12722) polymorphisms. Turkish Journal Kinesiology. 2023; 9: 195–203.

[19] Vaughn NH, Stepanyan H, Gallo RA, Dhawan A. Genetic factors in tendon injury: a systematic review of the literature. Orthopaedic Journal of Sports Medicine. 2017; 5: 2325967117724416.

[20] Posthumus M, September AV, O’Cuinneagain D, van der Merwe L, Schwellnus MP, Collins M. The association between the COL12A1 gene and anterior cruciate ligament ruptures. British Journal of Sports Medicine. 2010; 44: 1160–1165.

[21] Raleigh SM, Van der Merwe L, Ribbans WJ, Smith RKW, Schwellnus MP, Collins M. Variants within the MMP3 gene are associated with Achilles tendinopathy: possible interaction with the COL5A1 gene. British Journal of Sports Medicine. 2009; 43: 514–520.

[22] Sun Z, Cięszczyk P, Lulińska E, Dzitkowska-Zabielska M, Johne M, Humińska-Lisowska K, et al. Are COL22A1 gene polymorphisms rs11784270 and rs6577958 associated with susceptibility to a non-contact anterior cruciate ligament injury in Polish athletes? International Journal of Environmental Research and Public Health. 2022; 20: 515.

[23] Perini JA, Lopes LR, Guimarães JAM, Goes RA, Pereira LFA, Pereira CG, et al. Influence of type I collagen polymorphisms and risk of anterior cruciate ligament rupture in athletes: a case-control study. BMC Musculoskeletal Disorders. 2022; 23: 154.

[24] Li XY, Wang YL, Yang S, Liao CS, Li SF, Han PF. Correlation between vascular endothelial growth factor a gene polymorphisms and tendon and ligament injury risk: a systematic review and meta-analysis. Journal of Orthopaedic Surgery and Research. 2024; 19: 122.

[25] Lorenz K, Mastalerz A, Cywińska A, Garbacz A, Maculewicz E. Polymorphism of genes encoding inflammatory interleukins and the risk of anterior cruciate ligament injury: a systematic review and meta-analysis. International Journal of Molecular Sciences. 2024; 25: 4976.

[26] Wiggins AJ, Grandhi RK, Schneider DK, Stanfield D, Webster KE, Myer GD. Risk of secondary injury in younger athletes after anterior cruciate ligament reconstruction: a systematic review and meta-analysis. The American Journal of Sports Medicine. 2016; 44: 1861–1876.

[27] Van Melick N, Van Cingel RE, Brooijmans F, Neeter C, van Tienen T, Hullegie W, et al. Evidence-based clinical practice update: practice guidelines for anterior cruciate ligament rehabilitation based on a systematic review and multidisciplinary consensus. British Journal of Sports Medicine. 2016; 50: 1506–1515.

[28] Alentorn-Geli E, Myer GD, Silvers HJ, Samitier G, Romero D, Lázaro-Haro C, et al. Prevention of non-contact anterior cruciate ligament injuries in soccer players. Part 1: mechanisms of injury and underlying risk factors. Knee Surgery, Sports Traumatology, Arthroscopy. 2009; 17: 705–729.

[29] Bahr R, Krosshaug T. Understanding injury mechanisms: a key component of preventing injuries in sport. British Journal of Sports Medicine. 2005; 39: 324–329.

[30] Posthumus M, Collins M, Cook J, Handley CJ, Ribbans WJ, Smith RK, et al. Components of the transforming growth factor-beta family and the pathogenesis of human Achilles tendon pathology—a genetic association study. Rheumatology. 2010; 49: 2090–2097.

[31] Renstrom P, Ljungqvist A, Arendt E, Beynnon B, Fukubayashi T, Garrett W, et al. Non-contact ACL injuries in female athletes: an international Olympic committee current concepts statement. British Journal of Sports Medicine. 2008; 42: 394–412.

[32] Mattu AT, Ghali B, Linton V, Zheng A, Pike I. Prevention of non-contact anterior cruciate ligament injuries among youth female athletes: an umbrella review. International Journal of Environmental Research and Public Health. 2022; 19: 4648.

[33] Arundale AJ, Silvers‐Granelli HJ, Myklebust G. ACL injury prevention: where have we come from and where are we going? Journal of Orthopaedic Research. 2022; 40: 43–54.

[34] Malila S, Yuktanandana P, Saowaprut S, Jiamjarasrangsi W, Honsawek S. Association between matrix metalloproteinase-3 polymorphism and anterior cruciate ligament ruptures. Genetics and Molecular Research. 2011; 10: 4158–4165.

[35] Briški N, Vrgoč G, Knjaz D, Prgomet S, Tomić D, Malenica S, et al. Association of the matrix metalloproteinase 3 (MMP3) single nucleotide polymorphisms with tendinopathies: case-control study in high-level athletes. International Orthopaedics. 2021; 45: 1163–1168.

[36] Posthumus M, Collins M, van der Merwe L, O’Cuinneagain D, van der Merwe W, Ribbans WJ, et al. Matrix metalloproteinase genes on chromosome 11q22 and the risk of anterior cruciate ligament (ACL) rupture. Scandinavian Journal of Medicine & Science in Sports. 2012; 22: 523–533.

[37] Lulińska-Kuklik E, Rahim M, Moska W, Maculewicz E, Kaczmarczyk M, Maciejewska-Skrendo A. Are MMP3, MMP8 and TIMP2 gene variants associated with anterior cruciate ligament rupture susceptibility? Journal of Science and Medicine in Sport. 2019; 22: 753–757.